Stockreport

Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024

Gritstone bio, Inc.  (GRTS) 
Last gritstone bio, inc. earnings: 11/12 09:01 am Check Earnings Report
PDF -- IgG levels and neutralizing antibodies against variants of concern persisted for at least 12 months, consistent with previous findings -- -- Antigen-specific T cell [Read more]